Literature DB >> 26002948

Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Saak V Ovsepian1, Valerie B O'Leary2, Laszlo Zaborszky3.   

Abstract

Functional overviews of cholinergic mechanisms in the cerebral cortex have traditionally focused on the release of acetylcholine with modulator and transmitter effects. Recently, however, data have emerged that extend the role of acetylcholine and cholinergic innervations to a range of housekeeping and metabolic functions. These include regulation of amyloid precursor protein (APP) processing with production of amyloid β (Aβ) and other APP fragments and control of the phosphorylation of microtubule-associated protein (MAP) tau. Evidence has been also presented for receptor-ligand like interactions of cholinergic receptors with soluble Aβ peptide and MAP tau, with modulator and signaling effects. Moreover, high-affinity binding of Aβ to the neurotrophin receptor p75 (p75NTR) enriched in basalo-cortical cholinergic projections has been implicated in clearance of Aβ and nucleation of amyloid plaques. Here, we critically evaluate these unorthodox cholinergic mechanisms and discuss their role in neuronal physiology and the biology of Alzheimer's disease.
© The Author(s) 2015.

Entities:  

Keywords:  Alzheimer’s disease; acetylcholine; amyloid β; p75 neurotrophin receptor; tau protein; volume transmission

Mesh:

Substances:

Year:  2015        PMID: 26002948      PMCID: PMC4681696          DOI: 10.1177/1073858415588264

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  125 in total

1.  Differential cholinergic modulation of synaptic encoding and gain control mechanisms in rat hippocampus.

Authors:  Saak V Ovsepian
Journal:  Neurosci Res       Date:  2008-02-06       Impact factor: 3.304

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells.

Authors:  E Sadot; D Gurwitz; J Barg; L Behar; I Ginzburg; A Fisher
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

4.  Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulation.

Authors:  Laura Del Barrio; María Dolores Martín-de-Saavedra; Alejandro Romero; Esther Parada; Javier Egea; Jesús Avila; John Michael McIntosh; Susan Wonnacott; Manuela G López
Journal:  Toxicol Sci       Date:  2011-06-29       Impact factor: 4.849

5.  Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

Authors:  L R Fodero; S S Mok; D Losic; L L Martin; M I Aguilar; C J Barrow; B G Livett; D H Small
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

6.  Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.

Authors:  A Y Hung; C Haass; R M Nitsch; W Q Qiu; M Citron; R J Wurtman; J H Growdon; D J Selkoe
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 8.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

9.  Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.

Authors:  M Mousavi; E Hellström-Lindahl
Journal:  Neurochem Int       Date:  2008-12-07       Impact factor: 3.921

Review 10.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

View more
  9 in total

1.  Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.

Authors:  Valerie B O'Leary; Marie O'Connell; Inga Antyborzec; Vasilis Ntziachristos; J Oliver Dolly; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

2.  Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3ζ-binding sites reveals key differences between MAP2c and its homolog Tau.

Authors:  Séverine Jansen; Kateřina Melková; Zuzana Trošanová; Kateřina Hanáková; Milan Zachrdla; Jiří Nováček; Erik Župa; Zbyněk Zdráhal; Jozef Hritz; Lukáš Žídek
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

3.  Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain.

Authors:  Inga Antyborzec; Valerie B O'Leary; James O Dolly; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

4.  Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Authors:  Saak Victor Ovsepian; Valerie Bríd O'Leary
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 5.  Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Cyril Hoschl; Laszlo Zaborszky
Journal:  Neurosci Lett       Date:  2021-04-20       Impact factor: 3.197

6.  A Neurochemical Basis for Phenotypic Differentiation in Alzheimer's Disease? Turing's Morphogens Revisited.

Authors:  Heather T Whittaker; Jason D Warren
Journal:  Front Aging Neurosci       Date:  2017-03-29       Impact factor: 5.750

Review 7.  Cholinergic modulation of striatal microcircuits.

Authors:  Nilupaer Abudukeyoumu; Teresa Hernandez-Flores; Marianela Garcia-Munoz; Gordon W Arbuthnott
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

8.  Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz.

Authors:  Natalia Mast; Yong Li; Irina A Pikuleva
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

9.  Cerebral and Retinal Neurovascular Changes: A Biomarker for Alzheimer's Disease.

Authors:  Karru Venkata Ravi Teja; Tjm Tos Berendschot; Harry Steinbusch; A B Carroll Webers; R Praveen Murthy; P S Mathuranath
Journal:  J Gerontol Geriatr Res       Date:  2017-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.